SCHEMBL23416909

SCHEMBL23416909

CN1C(=O)c2c(ncn2CC(=O)Nc2ccc(-c3ccccc3)nn2)N(C)C1O

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PORCN Q9H237 7/20 0.58
▸ WNT3A P56704 4/20 0.41
▸ CYP3A4 P08684 3/20 0.41
▸ PRKD3 O94806 2/20 0.41
▸ PRKCG P05129 2/20 0.41
▸ PRKCB P05771 2/20 0.41
▸ PRKCA P17252 2/20 0.41
▸ PRKCH P24723 2/20 0.41
▸ PRKCI P41743 2/20 0.41
▸ PRKCE Q02156 2/20 0.41
▸ PRKCQ Q04759 2/20 0.41
▸ PRKCZ Q05513 2/20 0.41
▸ PRKCD Q05655 2/20 0.41
▸ PRKD1 Q15139 2/20 0.41
▸ CYP1A2 P05177 1/20 0.37
▸ CYP2D6 P10635 1/20 0.37
▸ KCNH2 Q12809 1/20 0.37
▸ MAP2K5 Q13163 1/20 0.37
▸ RIOK2 Q9BVS4 1/20 0.37
▸ TRPA1 O75762 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19997369 0.91 PORCN (0.47) PORCNWNT3ACYP3A4CYP2D6TRPA1
SCHEMBL19626366 0.87 PORCN (0.42) PORCNWNT3ATRPA1
SCHEMBL19626637 0.85 PORCN (0.51) PORCNWNT3A
SCHEMBL25454893 0.84 PORCN (0.58) PORCNWNT3ACYP3A4PRKD3PRKCG
SCHEMBL19997380 0.82 WNT3A (0.44) PORCNWNT3ATRPA1
SCHEMBL19626412 0.80 PORCN (0.40) PORCNWNT3APRKD3PRKCGPRKCB
SCHEMBL23416914 0.80 PORCN (0.40) PORCNWNT3APRKD3PRKCGPRKCB
SCHEMBL23416897 0.79 CYP1A2 (0.42) PORCNCYP3A4CYP1A2TRPA1
SCHEMBL19626552 0.79 TRPA1 (0.38) PORCNCYP3A4TRPA1
SCHEMBL20289870 0.78 WNT3A (0.43) PORCNWNT3A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230174533-A1 PURINE DIONES AS WNT PATHWAY MODULATORS AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2023-06-08 — — US disclosed
US-20210155623-A1 PURINE DIONES AS WNT PATHWAY MODULATORS AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2021-05-27 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230174533-A1 PURINE DIONES AS WNT PATHWAY MODULATORS WNT1, WNT3A, WNT3 PORCN 3369/4885WNT3A 2/4885CYP3A4 696/4885
US-20210155623-A1 PURINE DIONES AS WNT PATHWAY MODULATORS WNT1, WNT3A, WNT3 PORCN 3369/4885WNT3A 2/4885CYP3A4 696/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback